Coping with Stress and the Emergence of Multidrug Resistance in Fungi

PLoS Pathogens

Volumn 11, Issue 3, 2015, Pages 1-7

  Shor, Erika ^a   Perlin, David S ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CALCINEURIN; CALCIUM ION; CHITIN; ECHINOCANDIN; FLUCONAZOLE; GLYCEROL KINASE; HEAT SHOCK PROTEIN 90; PEPTIDES AND PROTEINS; PROTEIN ERG11; PROTEIN KINASE C; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANEUPLOIDY; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CHROMOSOMAL INSTABILITY; GENE MUTATION; GENETIC VARIABILITY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; CANDIDA; CRYPTOCOCCOSIS; FEMALE; FILOBASIDIELLA; GENETICS; IMMUNOCOMPROMISED PATIENT; LOW BIRTH WEIGHT; MALE; METABOLISM; NEWBORN; ORGAN TRANSPLANTATION;

FUNGI;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MALE; ORGAN TRANSPLANTATION;

EID: 84926472334     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004668     Document Type: Review

References (39)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, et al. (2012) Hidden killers: human fungal infections. Sci Transl Med 4: 165rv113. doi: 10.1126/scitranslmed.3004404 23253612
2. Ziakas PD, Kourbeti IS, Mylonakis E, (2014) Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. Clin Ther 36: 292–306 e291. doi: 10.1016/j.clinthera.2013.11.010 24439393
3. Greenberg RG, Benjamin DK, Jr. (2014) Neonatal candidiasis: Diagnosis, prevention, and treatment. J Infect 69 Suppl 1: S19–22. doi: 10.1016/j.jinf.2014.07.012 25129318
4. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, et al. (2007) Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 25: 5471–5489. 17909198
5. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M, (2011) Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol 49: 396–399. doi: 10.1128/JCM.01398-10 21068282
6. Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M, (2013) Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance. J Clin Microbiol 51: 2571–2581. doi: 10.1128/JCM.00308-13 23720791
7. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, et al. (2013) Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin Infect Dis 56: 1724–1732. doi: 10.1093/cid/cit136 23487382
8. Walker LA, Gow NA, Munro CA, (2010) Fungal echinocandin resistance. Fungal Genet Biol 47: 117–126. doi: 10.1016/j.fgb.2009.09.003 19770064
9. Cowen LE, Steinbach WJ, (2008) Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot Cell 7: 747–764. doi: 10.1128/EC.00041-08 18375617
10. Galhardo RS, Hastings PJ, Rosenberg SM, (2007) Mutation as a stress response and the regulation of evolvability. Crit Rev Biochem Mol Biol 42: 399–435. 17917874
11. Selmecki A, Forche A, Berman J, (2006) Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313: 367–370. 16857942
12. Sionov E, Lee H, Chang YC, Kwon-Chung KJ, (2010) Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 6: e1000848. doi: 10.1371/journal.ppat.1000848 20368972
13. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, et al. (2014) Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43: 78–81. doi: 10.1016/j.ijantimicag.2013.09.005 24182454
14. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M, (2011) Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008–2009. Antimicrob Agents Chemother 55: 561–566. doi: 10.1128/AAC.01079-10 21115790
15. Farmakiotis D, Tarrand JJ, Kontoyiannis DP, (2014) Drug-resistant Candida glabrata infection in cancer patients. Emerg Infect Dis 20: 1833–1840. doi: 10.3201/eid2011.140685 25340258
16. Lortholary O, Desnos-Ollivier M, Sitbon K, Fontanet A, Bretagne S, et al. (2011) Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients. Antimicrob Agents Chemother 55: 532–538. doi: 10.1128/AAC.01128-10 21078946
17. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr.Calandra TF, et al. (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48: 503–535. doi: 10.1086/596757 19191635
18. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, et al. (2012) Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 50: 1199–1203. doi: 10.1128/JCM.06112-11 22278842
19. Perlin DS, (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10: 121–130. 17569573
20. Perlin DS, (2014) Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management. Drugs 74: 1573–1585. doi: 10.1007/s40265-014-0286-5 25255923
21. White TC, Holleman S, Dy F, Mirels LF, Stevens DA, (2002) Resistance mechanisms in clinical isolates of Candida albicans. Antimicrobial Agents and Chemotherapy 46: 1704–1713. 12019079
22. Schubert S, Barker KS, Znaidi S, Schneider S, Dierolf F, et al. (2011) Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans. Antimicrob Agents Chemother 55: 2212–2223. doi: 10.1128/AAC.01343-10 21402859
23. Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, et al. (2012) Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Eukaryot Cell 11: 1289–1299. doi: 10.1128/EC.00215-12 22923048
24. Flowers SA, Colon B, Whaley SG, Schuler MA, Rogers PD, (2014) The contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Antimicrob Agents Chemother 59: 450–60. doi: 10.1128/AAC.03470-14 25385095
25. Selmecki AM, Dulmage K, Cowen LE, Anderson JB, Berman J, (2009) Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet 5: e1000705. doi: 10.1371/journal.pgen.1000705 19876375
26. Vermitsky J-P, Earhart KD, Smith WL, Homayouni R, Edlind TD, et al. (2006) Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol 61: 704–722. 16803598
27. Ram Y, Hadany L, (2014) Stress-induced mutagenesis and complex adaptation. Proc Biol Sci 281. pii: 20141025
28. Hadany L, Beker T, (2003) On the evolutionary advantage of fitness-associated recombination. Genetics 165: 2167–2179. 14704195
29. Coyle S, Kroll E, (2008) Starvation induces genomic rearrangements and starvation-resilient phenotypes in yeast. Mol Biol Evol 25: 310–318. 18032404
30. Chen G, Bradford WD, Seidel CW, Li R, (2012) Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 482: 246–250. doi: 10.1038/nature10795 22286062
31. Shin JH, Chae MJ, Song JW, Jung SI, Cho D, et al. (2007) Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia. J Clin Microbiol 45: 2385–2391. 17581937
32. Poláková S, Blume C, Zárate JA, Mentel M, Jørck-Ramberg D, et al. (2009) Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata. Proc Natl Acad Sci USA 106: 2688–2693. doi: 10.1073/pnas.0809793106 19204294
33. Forche A, Magee PT, Selmecki A, Berman J, May G, (2009) Evolution in Candida albicans populations during a single passage through a mouse host. Genetics 182: 799–811. doi: 10.1534/genetics.109.103325 19414562
34. Slater JL, Howard SJ, Sharp A, Goodwin J, Gregson LM, et al. (2011) Disseminated candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin. Antimicrob Agents Chemother 55: 3075–3083. doi: 10.1128/AAC.01686-10 21502627
35. Shor E, Fox CA, Broach JR, (2013) The yeast environmental stress response regulates mutagenesis induced by proteotoxic stress. PLoS Genet 9: e1003680. doi: 10.1371/journal.pgen.1003680 23935537
36. Cowen LE, (2009) Hsp90 orchestrates stress response signaling governing fungal drug resistance. PLoS Pathog 5: e1000471. doi: 10.1371/journal.ppat.1000471 19714223
37. Harrison BD, Hashemi J, Bibi M, Pulver R, Bavli D, et al. (2014) A tetraploid intermediate precedes aneuploid formation in yeasts exposed to fluconazole. PLoS Biol 12: e1001815. doi: 10.1371/journal.pbio.1001815 24642609
38. Sheltzer JM, Blank HM, Pfau SJ, Tange Y, George BM, et al. (2011) Aneuploidy drives genomic instability in yeast. Science 333: 1026–1030. doi: 10.1126/science.1206412 21852501
39. Lewis JS, 2ndWiederhold NP, Wickes BL, Patterson TF, Jorgensen JH, (2013) Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure. Antimicrob Agents Chemother 57: 4559–4561. doi: 10.1128/AAC.01144-13 23817368